您的位置: 首页 > 农业专利 > 详情页

Extended-release formulation for reducing the frequency of urination and method of use thereof
专利权人:
WELLESLEY PHARMACEUTICALS LLC
发明人:
Dill David A.
申请号:
NZ62661912
公开号:
NZ626619A
申请日:
2012.08.22
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
Disclosed the use of a pharmaceutical composition comprising acetaminophen in combination with either (1) one or more antidiuretic agents (e.g. desmopressin), or (2) one or more spasmolytics, or (3) an antimuscarinic agent selected from the group consisting of oxybutynin, solifenacin, darifenacin and atropine, in the manufacture of a medicament for treating nocturia in a subject in need thereof, wherein said pharmaceutical composition is formulated in an extended-release formulation and wherein said acetaminophen is formulated for administration at a daily dose of 1 mg to 2000 mg.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充